BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Pseudomonas infection
,
Intestine
,
Pharmacogenetics
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
class iii phosphatidylinositol 3- kinases
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for class iii phosphatidylinositol 3- kinases
Explore Curated Studies Results
Literature
Most Relevant Literature
Selective VPS34 Inhibitors: High Efficiency Design by Profiting from Small Structural Differences.
PIK3C3/VPS34 keeps body fats healthy.
Inhibition of Human Class I vs Class III Phosphatidylinositol 3'-Kinases.
Targeting VPS34 in autophagy: An update on pharmacological small-molecule compounds.
Neutrophil autophagy and NETosis in COVID-19: perspectives.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Prospective Multicenter Phase 2 Study of the Chemotherapy-Free Combination of the Intravenous Phos…
Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-II…
Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women Wit…
PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally A…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ